InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Poly(I:C) HMW | VISTA regulates microglia homeostasis and myelin phagocytosis, and is associa... | 2021 | Acta Neuropathol Commun. | Borggrewe M. et al. | DOI: 10.1186/s40478-021-01186-7 |
| Pam3CSK4 | Mycobacterium avium subsp. hominissuis (MAH) Microaggregate induction of host... | 2021 | Microb Pathog. | Keefe B.F. et al. | DOI: 10.1016/j.micpath.2021.104977 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia mucini... | 2021 | mBio | Becken B. et al. | DOI: 10.1128/mBio.00478-21 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia mucini... | 2021 | mBio | Becken B. et al. | DOI: 10.1128/mBio.00478-21 |
| LPS-EB (LPS from E. coli O111:B4) | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia mucini... | 2021 | mBio | Becken B. et al. | DOI: 10.1128/mBio.00478-21 |
| Pam3CSK4 | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia mucini... | 2021 | mBio | Becken B. et al. | DOI: 10.1128/mBio.00478-21 |
| ODN 1668 - TLR9 ligand | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia mucini... | 2021 | mBio | Becken B. et al. | DOI: 10.1128/mBio.00478-21 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Targeting TSP-1 decreased periodontitis by attenuating extracellular matrix d... | 2021 | Int Immunopharmacol. | Liu X. et al. | DOI: 10.1016/j.intimp.2021.107618 |
| LPS-EB (LPS from E. coli O111:B4) | Induction of OCT2 contributes to regulate the gene expression program in huma... | 2021 | Cell Rep. | Tamassia N. et al. | DOI: 10.1016/j.celrep.2021.109143 |
| R848 (Resiquimod) | Induction of OCT2 contributes to regulate the gene expression program in huma... | 2021 | Cell Rep. | Tamassia N. et al. | DOI: 10.1016/j.celrep.2021.109143 |
| G3-YSD | Temporal analysis of type 1 interferon activation in tumor cells following ex... | 2021 | Theranostics | Jagodinsky J.C. et al. | DOI: 10.7150/thno.54881 |
| RAW-Blue™ Cells | Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid fo... | 2021 | Int J Pharm X. | Jhundoo H.D. et al. | DOI: 10.1016/j.ijpx.2021.100080 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Intestinal permeability correlates with behavioural severity in very young ch... | 2021 | J Neuroimmunol. | Teske G. et al. | DOI: 10.1016/j.jneuroim.2021.577607 |
| c-di-GMP VacciGrade™ | Monocyte-Derived Dendritic Cells (moDCs) Differentiate into Bcl6 + Mature moD... | 2021 | J Immunol. | Mansouri S. et al. | DOI: 10.4049/jimmunol.2001347 |
| EndoFit™ OVA protein | Monocyte-Derived Dendritic Cells (moDCs) Differentiate into Bcl6 + Mature moD... | 2021 | J Immunol. | Mansouri S. et al. | DOI: 10.4049/jimmunol.2001347 |
| PMA - Phorbol myristate acetate | Gain-of-function variants in SYK cause immune dysregulation and systemic infl... | 2021 | Nat Genet. | Wang L. et al. | DOI: 10.1038/s41588-021-00803-4 |
| R406 | Gain-of-function variants in SYK cause immune dysregulation and systemic infl... | 2021 | Nat Genet. | Wang L. et al. | DOI: 10.1038/s41588-021-00803-4 |
| Pam3CSK4 | Six distinct NFκB signaling codons convey discrete information to distinguish... | 2021 | Immunity. | Adelaja A. et al. | DOI: 10.1016/j.immuni.2021.04.011 |
| Poly(I:C) HMW | Six distinct NFκB signaling codons convey discrete information to distinguish... | 2021 | Immunity. | Adelaja A. et al. | DOI: 10.1016/j.immuni.2021.04.011 |
| ODN 1668 - TLR9 ligand | Six distinct NFκB signaling codons convey discrete information to distinguish... | 2021 | Immunity. | Adelaja A. et al. | DOI: 10.1016/j.immuni.2021.04.011 |